annual ROE:
-881.26%-845.20%(-2343.87%)Summary
- As of today (August 16, 2025), AMRX annual return on equity is -881.26%, with the most recent change of -845.20% (-2343.87%) on December 31, 2024.
- During the last 3 years, AMRX annual ROE has fallen by -886.71% (-16269.91%).
- AMRX annual ROE is now -555.55% below its all-time high of 193.45%, reached on December 1, 2007.
Performance
AMRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-45.91%-12.81%(-38.70%)Summary
- As of today (August 16, 2025), AMRX quarterly return on equity is -45.91%, with the most recent change of -12.81% (-38.70%) on June 30, 2025.
- Over the past year, AMRX quarterly ROE has increased by +114.62% (+71.40%).
- AMRX quarterly ROE is now -115.16% below its all-time high of 302.92%, reached on December 1, 2006.
Performance
AMRX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AMRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2343.9% | +71.4% |
| 3 y3 years | -10000.0% | +39.4% |
| 5 y5 years | -807.6% | +36.4% |
AMRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -150.3% | +87.6% |
| 5 y | 5-year | -4619.3% | at low | -150.3% | +87.6% |
| alltime | all time | -555.5% | at low | -115.2% | +98.6% |
AMRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -45.91%(+38.7%) |
| Mar 2025 | - | -33.10%(-136.3%) |
| Dec 2024 | -881.26%(+2343.9%) | 91.24%(-124.7%) |
| Sep 2024 | - | -369.28%(+130.0%) |
| Jun 2024 | - | -160.53%(+55.1%) |
| Mar 2024 | - | -103.51%(+242.7%) |
| Dec 2023 | -36.06%(-58.1%) | -30.20%(-249.9%) |
| Sep 2023 | - | 20.15%(+241.5%) |
| Jun 2023 | - | 5.90%(-105.5%) |
| Mar 2023 | - | -107.45%(+20.1%) |
| Dec 2022 | -85.96%(-1677.2%) | -89.45%(+7.2%) |
| Sep 2022 | - | -83.47%(+10.1%) |
| Jun 2022 | - | -75.80%(>+9900.0%) |
| Mar 2022 | - | -0.21%(-104.0%) |
| Dec 2021 | 5.45%(-72.1%) | 5.24%(-40.9%) |
| Sep 2021 | - | 8.86%(+88.5%) |
| Jun 2021 | - | 4.70%(-146.4%) |
| Mar 2021 | - | -10.12%(-155.0%) |
| Dec 2020 | 19.50%(-120.1%) | 18.40%(+557.1%) |
| Sep 2020 | - | 2.80%(-103.9%) |
| Jun 2020 | - | -72.17%(+9.4%) |
| Mar 2020 | - | -65.98%(-30.3%) |
| Dec 2019 | -97.10%(+381.6%) | -94.66%(+27.2%) |
| Sep 2019 | - | -74.40%(+260.1%) |
| Jun 2019 | - | -20.66%(-17.0%) |
| Mar 2019 | - | -24.89%(+126.5%) |
| Dec 2018 | -20.16%(-1593.3%) | -10.99%(+29.9%) |
| Sep 2018 | - | -8.46%(-66.6%) |
| Jun 2018 | - | -25.36%(+3422.2%) |
| Mar 2018 | - | -0.72%(+118.2%) |
| Dec 2017 | 1.35%(-102.4%) | -0.33%(-99.3%) |
| Sep 2017 | - | -44.70%(-15.5%) |
| Jun 2017 | - | -52.89%(+5.1%) |
| Mar 2017 | - | -50.30%(+0.9%) |
| Dec 2016 | -55.98%(-1499.5%) | - |
| Dec 2016 | - | -49.87%(+183.0%) |
| Sep 2016 | - | -17.62%(-640.5%) |
| Jun 2016 | - | 3.26%(-5.8%) |
| Mar 2016 | - | 3.46%(-13.7%) |
| Dec 2015 | 4.00%(-40.8%) | 4.01%(+35.9%) |
| Sep 2015 | - | 2.95%(+247.1%) |
| Jun 2015 | - | 0.85%(-83.4%) |
| Mar 2015 | - | 5.11%(-23.7%) |
| Dec 2014 | 6.76%(-49.9%) | 6.70%(+18.6%) |
| Sep 2014 | - | 5.65%(+47.5%) |
| Jun 2014 | - | 3.83%(+1267.9%) |
| Mar 2014 | - | 0.28%(-97.8%) |
| Dec 2013 | 13.49%(+56.1%) | 12.88%(-15.4%) |
| Sep 2013 | - | 15.23%(-18.6%) |
| Jun 2013 | - | 18.71%(-13.4%) |
| Mar 2013 | - | 21.61%(+151.6%) |
| Dec 2012 | 8.64% | 8.59%(-25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | 11.60%(-0.2%) |
| Jun 2012 | - | 11.62%(+5.3%) |
| Mar 2012 | - | 11.03%(-6.3%) |
| Dec 2011 | 11.77%(-82.8%) | 11.77%(+11.9%) |
| Sep 2011 | - | 10.52%(-54.0%) |
| Jun 2011 | - | 22.88%(-20.9%) |
| Mar 2011 | - | 28.91%(-54.1%) |
| Dec 2010 | 68.56%(+161.8%) | 63.05%(-24.3%) |
| Sep 2010 | - | 83.30%(+7.7%) |
| Jun 2010 | - | 77.32%(-5.3%) |
| Mar 2010 | - | 81.62%(+191.8%) |
| Dec 2009 | 26.19%(+105.6%) | 27.97%(+120.1%) |
| Sep 2009 | - | 12.71%(+279.4%) |
| Jun 2009 | - | 3.35%(-73.5%) |
| Mar 2009 | - | 12.65%(+1.9%) |
| Dec 2008 | 12.74%(-93.4%) | 12.41%(+13.5%) |
| Sep 2008 | - | 10.93%(-76.6%) |
| Jun 2008 | - | 46.79%(-53.4%) |
| Mar 2008 | - | 100.36%(+6.9%) |
| Dec 2007 | 193.45%(-139.4%) | 93.86%(-102.9%) |
| Sep 2007 | - | -3290.44%(+55.4%) |
| Jun 2007 | - | -2116.88%(-1000.6%) |
| Mar 2007 | - | 235.06%(-22.4%) |
| Dec 2006 | -490.59%(+654.2%) | 302.92%(>+9900.0%) |
| Dec 2005 | -65.05%(+145.4%) | - |
| Sep 2004 | - | 1.50%(-134.4%) |
| Jun 2004 | - | -4.36%(-52.2%) |
| Mar 2004 | - | -9.12%(-64.8%) |
| Dec 2003 | -26.51%(-33.2%) | -25.89%(+4.0%) |
| Sep 2003 | - | -24.89%(-18.4%) |
| Jun 2003 | - | -30.51%(-23.4%) |
| Mar 2003 | - | -39.83%(-5.3%) |
| Dec 2002 | -39.68%(-6.0%) | -42.04%(-6.6%) |
| Sep 2002 | - | -45.02%(+1.4%) |
| Jun 2002 | - | -44.41%(+0.8%) |
| Mar 2002 | - | -44.06%(-6.8%) |
| Dec 2001 | -42.20%(-4.8%) | -47.29%(+2.9%) |
| Sep 2001 | - | -45.97%(-12.2%) |
| Jun 2001 | - | -52.35%(+2.9%) |
| Mar 2001 | - | -50.85%(-5.9%) |
| Dec 2000 | -44.32%(+39.3%) | -54.02%(+16.6%) |
| Sep 2000 | - | -46.31%(+55.5%) |
| Jun 2000 | - | -29.78%(+24.2%) |
| Mar 2000 | - | -23.98%(+39.7%) |
| Dec 1999 | -31.82%(-72.6%) | -17.17%(-70.1%) |
| Sep 1999 | - | -57.44%(-19.9%) |
| Jun 1999 | - | -71.72%(-15.0%) |
| Mar 1999 | - | -84.39%(-6.5%) |
| Dec 1998 | -116.10% | -90.28%(+51.9%) |
| Sep 1998 | - | -59.42%(+52.5%) |
| Jun 1998 | - | -38.97%(+164.0%) |
| Mar 1998 | - | -14.76% |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual return on equity?
- What is the all time high annual ROE for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of AMRX is -881.26%
What is the all time high annual ROE for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual return on equity is 193.45%
What is Amneal Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, AMRX annual return on equity has changed by -845.20% (-2343.87%)
What is Amneal Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of AMRX is -45.91%
What is the all time high quarterly ROE for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly return on equity is 302.92%
What is Amneal Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, AMRX quarterly return on equity has changed by +114.62% (+71.40%)